Key facts
- It has raised $540K; the latest was Seed Round ($540K) in Dec 2025.
- Notable investors include InnovateUK, PraeSeed.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Revela Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Revela Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Revela Health
Developer of diagnostic-support software designed for the non-invasive detection of endometriosis. The company's platform automatically analyses existing ultrasound scans using machine-learning-trained models to highlight subtle signs linked to endometriosis, returns structured image-based reports for clinician review, works with no extra appointments or hardware, and supports detailed, earlier treatment planning for clinicians globally seeking to reduce diagnosis delays.
- Sector
- Healthcare
- HQ
- Newcastle Upon Tyne, United Kingdom
- Founded
- 2023
- Employees
- 3
- Website
- revela.health/
- Ownership
- Privately Held (backing)
Revela Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Revela Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Revela Health in its N-PORT filings yet. We sweep new filings monthly.